TransMedics Group, Inc. (TMDX)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about TransMedics Group, Inc. (TMDX)

Go deeper and ask any question about TMDX

Company Performance

Current Price

as of Sep 13, 2024

$151.42

P/E Ratio

4241.46

Market Cap

$5.05B

Description

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.

Metrics

Overview

  • HQAndover, MA
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerTMDX
  • Price$151.42+1.53%

Trading Information

  • Market Cap$5.05B
  • Float96.60%
  • Average Daily Volume (1m)806,708
  • Average Daily Volume (3m)793,812
  • EPS$0.08

Company

  • Revenue$358.76M
  • Rev Growth (1yr)117.87%
  • Net Income$12.19M
  • Gross Margin60.51%
  • EBITDA Margin14.97%
  • EBITDA$17.11M
  • EV$5.47B
  • EV/Revenue15.24
  • P/E4,241.46
  • P/S14.89